48
Participants
Start Date
January 31, 2008
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
Rosiglitazone (Avandia) OR other diabetes medication currently prescribed to participant
Rosiglitazone 4-8mg/day, pill, from week -4 to week 32 OR other diabetes medication taken as prescribed from week -4 to week 32
conjugated linoleic acid (CLA)
3.2 g/day, capsule, week 0 to week 32
conjugated linoleic acid (CLA)
6.4 g/day, capsule, week 0 to week 32
The Ohio State University Clinical Research Center (Davis Medical Research Center), Columbus
Collaborators (2)
National Center for Complementary and Integrative Health (NCCIH)
NIH
GlaxoSmithKline
INDUSTRY
Bunge Loders Croklaan
INDUSTRY
LifeScan
INDUSTRY
Ohio State University
OTHER